Timing of the interim analysis in adaptive enrichment designs

Area of Science:

• Biostatistics
• Clinical Trial Design
• Personalized Medicine

Background:

• Personalized medicine necessitates study designs demonstrating efficacy in specific patient subgroups.
• Adaptive enrichment designs allow for target population selection and efficacy testing within a single trial.
• The optimal timing for interim analyses in these designs remains under-investigated.

Purpose of the Study:

• To investigate the impact of interim analysis timing on statistical power in adaptive enrichment trials.
• To evaluate power across different interim analysis timings for two distinct subgroup selection rules.

Main Methods:

• Simulation study of adaptive enrichment designs with normally distributed outcomes.
• Consideration of two classes of selection rules: effect difference and absolute effect estimates.
• Analysis of power based on varying interim analysis timings.

Main Results:

• The timing of the interim analysis can significantly impact statistical power.
• No universally optimal timing exists; power is contingent on treatment effects, subgroup prevalence, and selection rule.
• Scenarios demonstrating a substantial impact of timing on power were identified.

Conclusions:

• Careful consideration of interim analysis timing is essential for adaptive enrichment trial design.
• Operating characteristics must be evaluated for specific scenarios to determine appropriate timing.
• Tailoring timing to the specific clinical context and selection rule maximizes trial efficiency and power.